Tagged with regional

Pharma Puerto Rico is not only an important manufacturing hub, but is also positioning itself as a state-of-the-art center for R&D and clinical research. Iván Lugo, the executive director of the Industry University Research Center Inc. (INDUNIV), which brings together private sector, academia and government, discusses some of the island’s most…

Ferring The country manager of a research-driven, specialty biopharmaceutical group offering treatments for infertility outlines his firm’s approach for the socially conservative Algerian market. Your promotion as general manager of Ferring Algeria is quite recent. Can you tell us what were your priorities during the first year and how do you…

Novo Nordisk The global COO of the multinational at the forefront of the fight against diabetes explains why the Algerian market is so strategically important and how the ‘made in Algeria’ brand would have real potential at the regional level if only the government would remove impediments to export. As COO of Novo…

sales UCB has transformed into a specialty care pharma which focuses on bringing solutions to patients suffering from severe chronic diseases. The vice president and region head for Americas discusses how the company re-entered key markets in the Latin American space to drive future growth, how the company’s three flagships products…

development Glenmark’s country manager for Argentina discusses Argentina’s development expertise and how companies like Glenmark can capitalize on it through partnerships and collaborations.    How did you become part of Glenmark, and what was your main objective when you took the helm in Argentina? I joined Glenmark five years ago as…

regulation In July 2012 COFEPRIS (the Federal Commission for the Protection against Sanitary Risk) was recognized as a national regulatory authority of regional reference by the PAHO (Pan-American Health Organization), opening the doors to exports for the Mexican pharmaceutical industry. The executive director of the association representing domestic drug manufacturers discusses…

Pain Latin America continues to be in the spotlight at Grünenthal. The managing director for Mexico explains how the company is strengthening its product portfolio, working with stakeholders to create more awareness about pain treatment and on the good path to hit USD 100 million sales within the next four years.…

Bayer Bayer Malaysia’s managing director, Thomas Steffen, discusses the key differences and opportunities offered by the Malaysian market and calls for more information to help the promotion of oral contraception in order to strengthen women’s role in society. As you are managing the pharmaceutical business in both Malaysia and Singapore, how…

consumer healthcare GSK’s Consumer Healthcare’s regional manager for the southern cone discusses the countries longstanding commitment to the Argentinian consumer and how this history allows them to succeed in a country typically dominated by strong domestic brands.   There was recently a wave of M&A in Chile and elsewhere, do you see this…